Skip to main content

Table 4 Toxicities according to National Cancer Institute CTCAE (per patient)

From: Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker

Toxicities

Grade 1–2

Grade 3–4

 

No. of Pts

%

No. of Pts

%

Hematologic

    

   Leucopenia

13

17.8

0

0.0

   Neutropenia

10

13.7

8

11.0

   Anemia

12

16.4

0

0.0

   Thrombocytopenia

5

6.8

1

1.4

Non-hematologic

    

   Neuropathy

12

16.4

1

1.4

   AST/ALT abnormality

3

4.1

0

0.0

   Nausea

19

26.0

0

0.0

   Vomiting

9

12.4

0

0.0

   Mucositis

1

1.4

1

1.4

  1. AST, Aspartate aminotransferase; ALT, Alanine aminotransferase.